No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Kenny Gardner Named Chief People Officer at DaVita Kidney Care

Editor: What To Know

  • Kenny Gardner has been with DaVita for nearly a decade and most recently served the company as a group vice president (GVP), overseeing field operations in the Southeast U.
  • He has been an executive sponsor of DaVita’s renowned Redwoods recruiting program and a facilitator for DaVita University, which is DaVita’s in-house personal and professional development program.
  • “I am honored and excited to be CPO and look forward to this expanded responsibility to serve our thousands of teammates around the world.

DaVita Kidney Care recently announced Kenny Gardner as its new chief people officer (CPO). Kenny Gardner has been with DaVita for nearly a decade and most recently served the company as a group vice president (GVP), overseeing field operations in the Southeast U.S.

“Our teams of professionals give life to our patients, day in and day out. It is critical that we provide an environment for both our teammates and our patients to thrive,” said Javier Rodriguez, CEO of DaVita Inc. “I am confident that Kenny’s track record and proven leadership will take us to the next frontier.”

Gardner has held numerous roles since joining DaVita in 2011 as a regional operations director. He has been an executive sponsor of DaVita’s renowned Redwoods recruiting program and a facilitator for DaVita University, which is DaVita’s in-house personal and professional development program. In his latest role as GVP, he also led DaVita’s diagnostic laboratory along with a specialized, cross-functional team tasked with supporting DaVita teammates through innovative technology and tools.

“DaVita is a special place to work where everyone can belong,” said Gardner. “I am honored and excited to be CPO and look forward to this expanded responsibility to serve our thousands of teammates around the world.”

Prior to joining DaVita, Gardner worked as an investment banker for Morgan Stanley, where he focused on mergers and acquisitions. He holds a Bachelor of Science from Florida A&M University, along with a Master of Business Administration from Stanford.

In his free time, Gardner enjoys spending time with his family, giving back to his community, fitness, travel, reading and sports.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy